FLASCO 2025 Clinical Oncology Series – GI Updates

At the FLASCO 2025 Clinical Oncology Series: GI Cancer Updates on February 8, 2025, in Tampa, Florida, attendees had a chance to explore cutting-edge research and innovative treatment approaches in gastrointestinal cancers, including updates on clinical trials, novel therapies, and best practices for improving patient outcomes. The conference offered opportunities to collaborate with GI cancer thought leaders, providing attendees with a deeper understanding of the challenges and future directions in GI cancer care. This comprehensive approach ensured that participants were equipped with the knowledge and tools necessary to enhance their clinical practice and improve patient care.

Announcement

 

Photos

 

Presentations

9:05-9:25am
“Advances in Systemic Therapy for Gastroesophageal Cancers” by Mohamedtaki Tejani, MD

9:25-9:45 am
“Contemporary Surgical Management of Esophageal Cancer” by Gary Chmielewski, MD, FACS

11:35-11:55am
“HER2 Targeted Therapy in CRC” by Tiago Biachi, MD

1:20-1:40pm
“When to Choose Locoregional Therapy and When Two Therapies May Be Better Than One: Practical and Data Informed Approach” by Christopher Malone, MD

1:40-2:00pm
“Systemic Therapies for HCC: A Year in Review and Future Insights for the Community Oncologist” by Ahmed Zakari, MD

2:20-2:40pm
“Role of Immunotherapy and Combination Approaches in Advanced Cholangiocarcinoma” by Amit Mahipal, MD

2:40-3:00pm
“Targeted Therapy and Biomarker-Driven Treatments in Cholangiocarcinoma” by Sunyoung Lee, MD, PhD

3:20-3:40pm
“New Direction in PRRT” by Jonathan Strosberg, MD

3:40-4:00pm
“High Grade NEC – Current Landscape” by Renuka Iyer, MD